|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 57 studies with search of: | Lamivudina/ zidovudina OR Combivir[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Switch From Combivir to Truvada - Mitochondrial Effects
|
||||
| 2 | Completed |
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
|
||||
| 3 | Terminated |
GW873140 In Combination With Combivir In HIV Infected Subjects
|
||||
| 4 | Completed |
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
|
||||
| 5 | Completed |
Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis
|
||||
| 6 | Unknown † |
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
|
||||
| 7 | Unknown † |
Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-Child Transmission (PMTCT)
|
||||
| 8 | Completed |
SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
|
||||
| 9 | Active, not recruiting |
Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
|
||||
| 10 |
Completed
Has Results |
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
|
||||
| 11 | Unknown † |
Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
|
||||
| 12 | Completed |
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
|
||||
| 13 | Unknown † |
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
|
||||
| 14 | Suspended |
Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
|
||||
| 15 | Suspended |
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
|
||||
| 16 | Completed |
Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy
|
||||
| 17 | Recruiting |
Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia
|
||||
| 18 | Completed |
Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
|
||||
| 19 | Completed |
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
|
||||
| 20 |
Completed
Has Results |
Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|